Advocated for medicare reimbursement for skin substitutes that are used to heal wounds caused from diabetes.
2025 · 4th Quarter (Oct 1 - Dec 31)
BIOSTEM TECHNOLOGIES
Filed by BALLARD PARTNERS.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 13, 2026
- Income
- $120,000.00
- Expenses
- Not reported
- Registrant
- BALLARD PARTNERS
- Client
- BIOSTEM TECHNOLOGIES
- Filing UUID
- f9e2de01-51e0-4a4c-8838-96f10b409c20
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.